Prostate cancer in Asia: A collaborative report

Simple item page
dc.contributor.authorChen, Rui
dc.contributor.authorRen, Shancheng
dc.contributor.authorYiu, Ming Kwong
dc.contributor.authorFai, Ng Chi
dc.contributor.authorCheng, Wai Sam
dc.contributor.authorIan, Lap Hong
dc.contributor.authorNaito, Seiji
dc.contributor.authorMatsuda, Tadashi
dc.contributor.authorKehinde, Elijah
dc.contributor.authorKural, Ali
dc.contributor.authorChiu, Jason Yichun
dc.contributor.authorUmbas, Rainy
dc.contributor.authorWei, Qiang
dc.contributor.authorShi, Xiaolei
dc.contributor.authorZhou, Liqun
dc.contributor.authorHuang, Jian
dc.contributor.authorHuang, Yiran
dc.contributor.authorXie, Liping
dc.contributor.authorMa, Lulin
dc.contributor.authorYin, Changjun
dc.contributor.authorXu, Danfeng
dc.contributor.authorXu, Kexin
dc.contributor.authorYe, Zhangqun
dc.contributor.authorLiu, Chunxiao
dc.contributor.authorYe, Dingwei
dc.contributor.authorGao, Xin
dc.contributor.authorFu, Qiang
dc.contributor.authorHou, Jianquan
dc.contributor.authorYuan, Jianlin
dc.contributor.authorHe, Dalin
dc.contributor.authorPan, Tiejun
dc.contributor.authorDing, Qiang
dc.contributor.authorJin, Fengshuo
dc.contributor.authorShi, Benkang
dc.contributor.authorWang, Gongxian
dc.contributor.authorLiu, Xiuheng
dc.contributor.authorWang, Dongwen
dc.contributor.authorShen, Zhoujun
dc.contributor.authorKong, Xiangbo
dc.contributor.authorXu, Wanhai
dc.contributor.authorDeng, Yaoliang
dc.contributor.authorXia, Haibo
dc.contributor.authorCohen, Alexa N.
dc.contributor.authorGao, Xu
dc.contributor.authorXu, Chuanliang
dc.contributor.authorSun, Yinghao
dc.contributor.authorConsortium, Chinese Prostate Canc
dc.date.accessioned2023-02-21T12:42:49Z
dc.date.available2023-02-21T12:42:49Z
dc.date.issued2014-01-01
dc.description.abstractThe incidence of prostate cancer (PCa) within Asian population used to be much lower than in the Western population
dc.description.abstracthowever, in recent years the incidence and mortality rate of PCa in some Asian countries have grown rapidly. This collaborative report summarized the latest epidemiology information, risk factors, and racial differences in PCa diagnosis, current status and new trends in surgery management and novel agents for castration-resistant prostate cancer. We believe such information would be helpful in clinical decision making for urologists and oncologists, health-care ministries and medical researchers. (C) 2014 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier (Singapore) Pte Ltd.
dc.description.issue1
dc.description.issueOCT
dc.description.pages15-29
dc.description.volume1
dc.identifier.doi10.1016/j.ajur.2014.08.007
dc.identifier.urihttps://hdl.handle.net/11443/2851
dc.identifier.urihttp://dx.doi.org/10.1016/j.ajur.2014.08.007
dc.identifier.wosWOS:000215386600006
dc.publisherELSEVIER SINGAPORE PTE LTD
dc.relation.ispartofASIAN JOURNAL OF UROLOGY
dc.subjectProstate cancer
dc.subjectAsian population
dc.subjectEpidemiology
dc.subjectRisk factors
dc.subjectRacial differences
dc.subjectSurgery management
dc.titleProstate cancer in Asia: A collaborative report
dc.typeArticle

Files

Collections

WOS